# GenSight Biologics S.A. (GSGTF)

> Healthcare · FR · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GSGTF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | € 1.0K | € -12.23M | € -3.21M | € 12.86M | € -24.93M |
| 2024 | € 1.55M | € -14.51M | € -13.40M | € 19.11M | € -26.92M |
| 2023 | € 1.34M | € -27.82M | € -26.47M | € 18.43M | € -30.67M |
| 2022 | € 4.01M | € -30.17M | € -37.53M | € 12.65M | € -15.28M |
| 2021 | € 7.63M | € -34.12M | € -20.85M | € 12.57M | € 15.99M |
| 2020 | € 5.50M | € -42.58M | € -19.72M | € 14.45M | € 11.67M |
| 2019 | € 2.41M | € -38.33M | € -35.18M | € 7.95M | € 11.75M |
| 2018 | € 2.75M | € -42.31M | € -36.90M | € 3.44M | € 23.87M |
| 2017 | € 4.75M | € -30.96M | € -24.42M | € 3.03M | € 55.00M |
| 2016 | € 3.91M | € -28.74M | € -25.81M | € 2.92M | € 53.34M |
| 2015 | € 4.68M | € -17.96M | € -16.83M | € 622.2K | € 29.33M |
| 2014 | € 1.45M | € -8.80M | € -7.52M | € 632.3K | € 10.58M |
| 2013 | € 1.20M | € -3.64M | € -3.02M | € 0 | € 16.97M |
| 2012 | N/A | N/A | N/A | € 0 | € -66.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.52 |
| Liabilities / Eq | -1.33 |
| Current Ratio | 0.39 |

## Other views

- [Metrics](https://sponda.capital/en/GSGTF.md)
- [Charts](https://sponda.capital/en/GSGTF/charts.md)
- [Compare](https://sponda.capital/en/GSGTF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.